[1]
W. J. Caputo, G. Fahoury, D. Beggs, and P. Monterosa, “Dalbavancin and moleculight in the COVID-19 pandemic”, J Clin Intensive Care Med, vol. 8, no. 1, pp. 001–003, Mar. 2023.